There isn’t just one kind of treatment: the different types of stem cell therapy vary by where the cells come from and what they can become.
The main options include mesenchymal, hematopoietic, MUSE, and exosome-based therapies, sourced from your own body or a donor.
This guide walks through each type, what’s FDA approved, and how to spot a clinic worth trusting.
If you’ve been researching regenerative medicine, you’ve probably noticed that “stem cell therapy” gets used as a catch-all term for very different treatments.
Two clinics might both offer “stem cell therapy” while using completely different cell types, sources, and delivery methods, with very different evidence behind each one.
Knowing the different types of stem cell therapy, how they’re sourced, and what’s actually backed by research helps you ask better questions and set realistic expectations before you commit to treatment.
What Are the Main Types of Stem Cell Therapy?
Stem cell therapy falls into a few core categories: pluripotent versus adult stem cells based on how many cell types they can become, autologous versus allogeneic based on whether the cells come from you or a donor, and specific cell types like mesenchymal, hematopoietic, MUSE, and exosome-based therapies, each suited to different conditions.
Most people hear “stem cell therapy” and picture a single injection.
In reality, doctors group these treatments a few different ways, and knowing the difference matters if you’re deciding what might help your condition.
Every stem cell shares one basic trait: it can turn into more specialized cells, which is the foundational role stem cells play inside the body.
Doctors sort therapies three ways.
The first is by potency, meaning how many different cell types a stem cell can become.
The second is by source, whether the cells come from your own body (autologous) or a donor (allogeneic).
The third is by the specific cell type used, since mesenchymal, hematopoietic, MUSE, and exosome-based therapies each behave differently once they’re in the body.
A stem cell therapy program built around the right combination of these factors is what separates an evidence-based protocol from guesswork.
Stem Cells by Potency: Pluripotent, Multipotent, and Adult Stem Cells
Potency describes how flexible a stem cell is.
Cells with more potential can become more types of tissue, but they also come with more restrictions on how they can legally and safely be used.
Embryonic and Induced Pluripotent Stem Cells (iPSCs)
Pluripotent stem cells can turn into almost any cell type in the body.
Embryonic stem cells are the original example, but their use is tightly restricted for ethical and regulatory reasons.
Induced pluripotent stem cells (iPSCs) solve part of that problem.
Scientists take an adult cell, like a skin cell, and reprogram it back into a pluripotent state in a lab.
A detailed review of cell therapy research found that only about 11% of clinical iPSC studies are testing actual therapeutic use rather than research applications.
Most iPSC therapies remain experimental.
Adult (Multipotent) Stem Cells
Adult stem cells, also called multipotent stem cells, can only become a limited range of related cell types.
A mesenchymal stem cell found in bone marrow, for example, can become bone, cartilage, or fat cells, but not a nerve cell.
This more limited scope is actually an advantage for most current treatments.
Adult stem cells are easier to source, don’t carry the same ethical questions as embryonic cells, and have a much longer track record in clinical use.
Nearly every stem cell therapy available today, including the ones used for orthopedic, autoimmune, and blood disorders, relies on adult stem cells rather than pluripotent ones.
What’s the Difference Between Autologous and Allogeneic Stem Cell Therapy?
Autologous stem cell therapy uses cells collected from your own body, usually from bone marrow or fat tissue, while allogeneic therapy uses cells from a donor, such as umbilical cord tissue.
Autologous treatment avoids rejection risk but takes more collection time, while allogeneic cells are available immediately and can be more consistently potent.
Autologous Stem Cell Therapy
With autologous therapy, your own cells are collected, processed, and then reintroduced into your body.
Because the cells come from you, there’s no risk of immune rejection or disease transmission from another donor.
The tradeoff is supply and quality.
Your cell yield and potency depend on your age and health, since older donors typically produce fewer, less active stem cells than younger ones.
Collection also takes a separate procedure, whether that’s a bone marrow aspiration or a fat tissue extraction, before treatment can happen.
Allogeneic Stem Cell Therapy
Allogeneic therapy uses cells from a donor instead of the patient.
Common sources include umbilical cord tissue, placental tissue, and donated bone marrow.
Because these cells come from young, healthy donor tissue, they tend to be more consistent and available on demand, without a separate collection procedure for the patient.
Careful donor screening and processing standards have reduced the rejection risk that once made allogeneic treatment more complicated.
Two related approaches are worth knowing: syngeneic transplants use cells from an identical twin, and haploidentical transplants use a half-matched family donor.
What Are Mesenchymal Stem Cells (MSCs) and Why Are They So Widely Used?
Mesenchymal stem cells (MSCs) are adult stem cells found in bone marrow, fat tissue, and umbilical cord tissue that can become bone, cartilage, muscle, and fat cells.
They’re the most studied and widely used stem cell type in regenerative medicine because of their anti-inflammatory and tissue-repair properties.
MSCs make up a tiny fraction of the cells in bone marrow, roughly 0.001% of non-hematopoietic cells in a typical aspirate, which is why labs often expand them in culture before use.
Once isolated, they’re valued less for becoming new tissue directly and more for the signals they release, since MSCs secrete proteins that calm inflammation and recruit the body’s own repair processes.
That immune-modulating effect is why MSCs show up in protocols for autoimmune conditions, joint damage, and chronic inflammation.
Hematopoietic Stem Cell Transplants: Treating Blood and Immune Disorders
Hematopoietic stem cells (HSCs) are the cells that give rise to every type of blood cell, including red blood cells, white blood cells, and platelets.
They’re found in bone marrow, peripheral blood, and umbilical cord blood.
HSC transplants are the oldest and most established form of stem cell therapy, used for decades to treat leukemia, lymphoma, and other blood or immune system disorders.
The results can be substantial: in one review of hematopoietic stem cell transplants for multiple sclerosis, 79% of patients showed improvement in disability status after treatment.
Unlike MSC therapy, which is often used for tissue repair and inflammation, HSC transplants work by replacing a patient’s damaged or diseased blood-forming system entirely.
That makes the procedure more intensive, typically involving chemotherapy or radiation beforehand to clear out the existing bone marrow.
What Are MUSE Cells and How Are They Different From MSCs?
Multilineage-differentiating stress enduring (MUSE) cells are a small, naturally occurring subset of mesenchymal stem cells, identified by a marker called SSEA-3, that can survive harsh conditions and home in on damaged tissue on their own.
Unlike standard MSCs, MUSE cells don’t need to be injected directly at an injury site to find their way there.
Most MSCs stay wherever they’re placed.
MUSE cells behave differently: research shows they can travel through the bloodstream and seek out damaged tissue on their own, homing in on the exact area that needs repair.
This targeting ability, combined with the ability to survive stressful conditions like low oxygen, has driven clinical trials in acute heart attack, stroke, ALS, and spinal cord injury.
The practical differences between MUSE cells and standard mesenchymal stem cells come down to targeting and survivability rather than the source tissue, since both are typically derived from similar donor material.
A MUSE cell therapy program built around that homing ability is what makes this cell type worth considering separately from standard MSC treatment.
Exosome Therapy and NK Cell Therapy: Beyond Traditional Stem Cells
Not every regenerative treatment involves a living stem cell.
Two related therapies, exosomes and natural killer (NK) cells, work through different mechanisms but are often grouped alongside stem cell treatments.
Exosome Therapy
Exosomes are tiny particles released by stem cells, not stem cells themselves.
They carry proteins, genetic material, and growth factors that signal nearby cells to repair tissue and reduce inflammation.
Because exosomes contain no living cells, they carry a different risk profile than stem cell therapy and can be more precisely dosed.
Exosome therapy is often used alongside stem cell treatment to amplify the signaling effect, particularly for skin, joint, and inflammatory applications.
Natural Killer (NK) Cell Therapy
NK cells are a type of white blood cell, not a stem cell, that identifies and destroys damaged, infected, or abnormal cells as part of the immune system’s first line of defense.
NK cell therapy is used to support immune function rather than repair tissue directly, which makes it a common complement to stem cell or exosome protocols for patients focused on immune resilience and healthy aging.
How Cellular Hope Institute Approaches Stem Cell Therapy
Every type of stem cell therapy covered here, mesenchymal, MUSE, exosome, and NK cell, is available through our regenerative cell therapies program in Cancún.
We build protocols around matching the right cell type to each patient’s condition rather than offering one treatment for every diagnosis.
Every batch of cells used in treatment comes with certificate of analysis documentation, so you know exactly what you’re receiving before treatment begins.
Our medical team, whose backgrounds you can review on our who we are page, designs each protocol around your specific condition, health history, and goals rather than a standard package.
Understanding the different types of stem cell therapy is the first step toward knowing which one, if any, fits your condition.
From there, Cellular Hope Institute can walk you through the specific cell type, source, and evidence behind a treatment plan built for you.
FAQs: Types of Stem Cell Therapy
What are the main types of stem cells used in therapy?
The main types are mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and MUSE cells, along with related therapies like exosomes and NK cells. They’re also grouped by potency (pluripotent versus adult) and by source (autologous versus allogeneic).
What’s the difference between autologous and allogeneic stem cell therapy?
Autologous therapy uses cells collected from your own body, usually bone marrow or fat tissue, while allogeneic therapy uses cells from a donor, often umbilical cord or placental tissue. Autologous cells avoid rejection risk but require a separate collection procedure, while allogeneic cells are available immediately.
Are MUSE cells the same as mesenchymal stem cells?
MUSE cells are a small subset found within mesenchymal stem cell populations, identified by a marker called SSEA-3. Unlike standard MSCs, MUSE cells can travel through the bloodstream and home in on damaged tissue on their own, which sets them apart functionally even though they come from similar source tissue.
What conditions can different types of stem cell therapy treat?
Hematopoietic stem cell transplants treat blood cancers and immune disorders. Mesenchymal stem cells are used for autoimmune conditions, joint and orthopedic damage, and chronic inflammation. MUSE cells, exosomes, and NK cells are being studied for heart, neurological, skin, and immune-related applications, many still in clinical trials.
How do I know if a stem cell clinic is legitimate?
A legitimate clinic will tell you exactly which cell type and source you’re receiving, provide a certificate of analysis for the cells used, and point to published data rather than testimonials. Guarantees of specific results or pressure to book quickly are red flags.
What’s the difference between exosome therapy and stem cell therapy?
Exosome therapy uses particles released by stem cells rather than living cells themselves. Exosomes carry proteins and genetic material that signal nearby cells to repair tissue, while stem cell therapy introduces living cells that can develop into or support the growth of new tissue.